Search
SOLACI Congress
Jornadas CR Concurso banner en
Other

Tricuspid Regurgitation, TriBicaval Registry

Tricuspid regurgitation (TR) is a condition whose prevalence is expected to increase in the coming years. Surgery presents important challenges and is associated with a non-negligible mortality rate. Percutaneous treatment is...
Dr. Carlos Fava -
ESC 2025

Watch again – New Guidelines for the Management of Heart Valve Disease: Implications for Interventional Cardiology

You can now watch our webinar on “New Guidelines for the Management of Heart Valve Disease: Implications for Interventional Cardiology”, held via...
solaci -

SOLACI Scientific Coverage

ESC 2025: New Guidelines for the Management of Valvular Aortic Disease - Implications for Interventional Cardiology

Watch now!

SOLACI-SOCIME 2025 Congress

SOLACI-SOCIME 2025 Congress Certificates

Get your certificate of attendance or scientific participation

Selected Presentations

See slides selected by the editorial committee of our website

The Best Images

Find here all the photos of the event throughout its 3 days

SOLACI-SOCIME 2025 Posters

Discover and review the works presented during the SOLACI-SOCIME 2025 Congress

Day 1 Summary

Relive the main scientific activities of the first day

Day 2 Summary

Relive the main scientific activities of the second day

Day 3 Summary

Relive the main scientific activities of the third day

All the Event News

Find all the news from SOLACI-SOCIME 2025

Featured Articles

News

Other

Tricuspid Regurgitation, TriBicaval Registry

Tricuspid regurgitation (TR) is a condition whose prevalence is expected to increase in the coming years. Surgery...
Dr. Carlos Fava -
Coronary disease

IVI-Guided PCI vs Coronary Artery Bypass Surgery in Left Main Coronary or Multivessel Disease

Several randomized clinical trials have demonstrated the superiority of coronary artery bypass grafting (CABG) over percutaneous coronary...
Dr. Andrés Rodríguez -
Mitral valve

Edge-To-Edge Treatment with PASCAL: Are There Sex-Specific Differences?

Mitral regurgitation (MR) is a common valve disease associated with heart failure, hospitalizations, and mortality.  In women, it...
Dr. Carlos Fava -
Antithrombotic Anticoagulants

ESC 2025 | HI-PRO: Extended Apixaban for Recurrence Prevention in Provoked DVT/PE

Patients with provoked venous thromboembolism (VTE) usually discontinue anticoagulation after 3 to 6 months. However, in the...
Dr. Omar Tupayachi -

Institutional News

News

ESC 2025

Watch again – New Guidelines for the Management of Heart Valve Disease: Implications for Interventional Cardiology

You can now watch our webinar on “New Guidelines for the Management of Heart Valve Disease: Implications...
solaci -
ESC 2025

ESC 2025: Results of the NEO-MINDSET study — exclusive presentation and analysis with Dr. Pedro Lemos

Following the presentation of the NEO-MINDSET study in the Late Breaking Clinical Trials sessions at the European...
solaci -
Institutional News

SOLACI Webinar – New Guidelines for the Management of Valvular Heart Disease: Implications for Interventional Cardiology

A new SOLACI virtual scientific event is coming up as part of the scientific coverage of the...
solaci -
Institutional News

SOLACI-SOCIME 2025: Day 3 Highlights

The third and final day of the SOLACI-SOCIME 2025 Congress concluded with a high-impact scientific agenda, featuring...
solaci -
spot_img

International Congresses

Latest Congress

ESC 2025

Discover the most important scientific articles of ESC 2025 Congress, carried out between August 29 & September 1 in Madrid, Spain.

Learn more
ESC 2025

Watch again – New Guidelines for the Management of Heart Valve Disease: Implications for Interventional Cardiology

You can now watch our webinar on “New Guidelines for the Management of Heart Valve Disease: Implications for Interventional Cardiology”, held via Zoom...
Learn More
ESC 2025

ESC 2025: Results of the NEO-MINDSET study — exclusive presentation and analysis with Dr. Pedro Lemos

Following the presentation of the NEO-MINDSET study in the Late Breaking Clinical Trials sessions at the European Society of Cardiology Congress (ESC 2025),...
Learn More
Antithrombotic Anticoagulants

ESC 2025 | HI-PRO: Extended Apixaban for Recurrence Prevention in Provoked DVT/PE

Patients with provoked venous thromboembolism (VTE) usually discontinue anticoagulation after 3 to 6 months. However, in the presence of persistent factors such as...
Learn More

EuroPCR 2025

Learn more

ACC 2025

Learn more

AHA 2024

Learn more

TCT 2024

Learn more

SOLACI Meetings

Hilton Hotel, Buenos Aires, Argentina

SOLACI-CACI 2024

Discover the best presentations, videos, and images from SOLACI-CACI 2024, held from August 7 to 9, 2024, in Buenos Aires.

More information
Institutional News

SOLACI-CACI 2024 – Live Cases

Relive the Live Cases from the SOLACI-CACI 2024 Congress, held from August 7 to 9, 2024, at the Hilton Hotel in Buenos Aires. SOLACI-CACI...
Learn More
Institutional News

SOLACI-CACI 2024 – Presentations day 3

Discover the highlights of the third day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires,...
Learn More
Institutional News

SOLACI-CACI 2024 – Day 2 Presentations

Discover the highlights of the second day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires,...
Learn More

SOLACI-SBHCI 2023

Featured Content

Live Cases

INTRAVASCULAR IMAGING & Angio-based Physiology guided complex LEFT MAIN BIFURCATION, SOLACI-SBHCI 23

solaci - 0
✔️ SOLACI-SBHCI 2023 - International Live Case | INTRAVASCULAR IMAGING & Angio-based Physiology guided complex LEFT MAIN BIFURCATION ✔️ Site: Nanjing First Hospital, Nanjing, China ✔️...

Transcatheter Pulmonary Valve Replacement | SOLACI-SBHCI 2023 – International Live Case

solaci - 0
✔️ SOLACI-SBHCI 2023 - International Live Case | Transcatheter pulmonary valve replacement. ✔️ Site: Medicine, Doha, Qatar. ✔️ August 3, 2023, Arpoador Room, Windsor Oceánico.

TAVI for Pure Aortic Valve Regurgitation Using a Newself-Expanding Technology | SOLACI-SBHCI 2023

solaci - 0
✔️ SOLACI-SBHCI 2023 - International Live Case | TAVI for Pure Aortic Valve Regurgitation Using a Newself-Expanding Technology ✔️ Site: Nanjing First Hospital, Nanjing, China ✔️...

Presentations

SOLACI-SBHCI 2023 | Insights from the LATAM Peripheral Registry – Dr. Maximiliano Rossi

solaci - 0
Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Maximiliano Rossi, entitled “Insights from the LATAM Peripheral...

SOLACI-SBHCI 2023 | Vascular Access for Large Bore Introducers and Review on Arterial Sheaths – Dr. Guilherme Bernardi

solaci - 0
Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Guilherme Bernardi, entitled “Vascular Access for Large Bore...

SOLACI-SBHCI 2023 | Patient-centered Selection Anti-platelet Treatment for ACS-PCI Patients: Real World Evidence of Prasugrel – Dr. Roxana Mehran

solaci - 0
Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Roxana Mehran, entitled “Patient-centered Selection Anti-platelet Treatment for...

ProEducar

The best images of the 13th ProEducar Fellows Course at SOLACI-SBHCI 2023

solaci - 0
Relive the best images of the 13th ProEducar Fellows Course held on August 2 during the SOLACI-SBHCI 2023 Congress in the URCA Room of...

See the Presentations of the 13th ProEducar Fellows Course

solaci - 0
  During SOLACI-SBHCI 2023, our traditional education program for young interventionists ProEducar Fellows Course was held.  Discover the presentations of the prestigious interventionists that made part of this 13th edition...

Best Moments

The Best Images of SOLACI-SBHCI 2023

solaci - 0
Relive the best moments of the largest gathering of interventional cardiologists in Latin America, held between August 2 and 4, 2023 at the Windsor...

The best images of the 13th ProEducar Fellows Course at SOLACI-SBHCI 2023

solaci - 0
Relive the best images of the 13th ProEducar Fellows Course held on August 2 during the SOLACI-SBHCI 2023 Congress in the URCA Room of...

SOLACI-SBHCI 2023

Learn more

SOLACI-SOCIME 2022

Learn more

SOLACI-CACI 2021

Learn more

SOLACI-SBHCI 2019

Learn more

ProEducar

Educational Newsletter N° 120

Special Edition on Durability in TAVR

2025 Edition

Educational Newsletter N° 119

Special Supplement on Management and Assessment of Coronary Calcium

2024 Edition

Educational Newsletter N° 118

New Applications of Cardiac Tomography for Coronary Interventions

2023 Edition

Educational Newsletter N° 117

Extraordinary Supplement on Coronary Physiology in the Hemodynamics Laboratory

2022 Edition

Educational Webinars

Access all the virtual educational activities from SOLACI on various topics related to cardiovascular interventions.

I want to learn more!

Clinical Cases

SOLACI Peripheral

Learn more

Fellow's Corner

Learn more

SOLACI Areas

SOLACI Sessions

More Information

SOLACI Peripheral

More Information

CHIP LATAM

More Information

ProEducar

More Information

MIL Group

More Information

Congenital Heart Disease

More Information

SOLACI Research

More Information

SOL SOLACI

More Information

Nurses and Technicians

More Information

Most Read Articles

Tricuspid Regurgitation, TriBicaval Registry

Dr. Carlos Fava - 0
Tricuspid regurgitation (TR) is a condition whose prevalence is expected to increase in the coming years. Surgery presents important challenges and is associated with...

IVI-Guided PCI vs Coronary Artery Bypass Surgery in Left Main Coronary or Multivessel Disease

Dr. Andrés Rodríguez - 0
Several randomized clinical trials have demonstrated the superiority of coronary artery bypass grafting (CABG) over percutaneous coronary intervention (PCI) in patients with left main...

Edge-To-Edge Treatment with PASCAL: Are There Sex-Specific Differences?

Dr. Carlos Fava - 0
Mitral regurgitation (MR) is a common valve disease associated with heart failure, hospitalizations, and mortality.  In women, it is often overlooked and some analyses have...

Watch again – New Guidelines for the Management of Heart Valve Disease: Implications for Interventional Cardiology

solaci - 0
You can now watch our webinar on “New Guidelines for the Management of Heart Valve Disease: Implications for Interventional Cardiology”, held via Zoom on...

ESC 2025: Results of the NEO-MINDSET study — exclusive presentation and analysis with Dr. Pedro Lemos

solaci - 0
Following the presentation of the NEO-MINDSET study in the Late Breaking Clinical Trials sessions at the European Society of Cardiology Congress (ESC 2025), Dr....

ESC 2025 | HI-PRO: Extended Apixaban for Recurrence Prevention in Provoked DVT/PE

Dr. Omar Tupayachi - 0
Patients with provoked venous thromboembolism (VTE) usually discontinue anticoagulation after 3 to 6 months. However, in the presence of persistent factors such as obesity,...

ESC 2025 | BETAMI-DANBLOCK: Randomized Discontinuation of Beta-Blockers after MI

Dr. Omar Tupayachi - 0
The routine use of beta-blockers after acute myocardial infarction (AMI) has been a historical recommendation based on studies prior to the era of percutaneous...

ESC 2025 | DOUBLE-CHOICE: Anesthesia Strategies and Self-Expanding Valves in TAVI

Dr. Omar Tupayachi - 0
TAVI has become the predominant treatment for severe aortic stenosis. The DOUBLE-CHOICE trial analyzed two key aspects: anesthesia strategy and the type of self-expanding...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Tricuspid Regurgitation, TriBicaval Registry

Dr. Carlos Fava - 0
Tricuspid regurgitation (TR) is a condition whose prevalence is expected to increase in the coming years. Surgery presents important challenges and is associated with...

IVI-Guided PCI vs Coronary Artery Bypass Surgery in Left Main Coronary or Multivessel Disease

Dr. Andrés Rodríguez - 0
Several randomized clinical trials have demonstrated the superiority of coronary artery bypass grafting (CABG) over percutaneous coronary intervention (PCI) in patients with left main...

Edge-To-Edge Treatment with PASCAL: Are There Sex-Specific Differences?

Dr. Carlos Fava - 0
Mitral regurgitation (MR) is a common valve disease associated with heart failure, hospitalizations, and mortality.  In women, it is often overlooked and some analyses have...

Institutional News

Watch again – New Guidelines for the Management of Heart Valve Disease: Implications for Interventional Cardiology

solaci - 0
You can now watch our webinar on “New Guidelines for the Management of Heart Valve Disease: Implications for Interventional Cardiology”, held via Zoom on...

ESC 2025: Results of the NEO-MINDSET study — exclusive presentation and analysis with Dr. Pedro Lemos

solaci - 0
Following the presentation of the NEO-MINDSET study in the Late Breaking Clinical Trials sessions at the European Society of Cardiology Congress (ESC 2025), Dr....

SOLACI Webinar – New Guidelines for the Management of Valvular Heart Disease: Implications for Interventional Cardiology

solaci - 0
A new SOLACI virtual scientific event is coming up as part of the scientific coverage of the ESC 2025 Congress. This session will focus on...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy